Suppr超能文献

未分化型胃腺癌:三种组织学类型的预后影响。

Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types.

机构信息

Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

出版信息

World J Surg Oncol. 2012 Nov 26;10:254. doi: 10.1186/1477-7819-10-254.

Abstract

BACKGROUND

The prognostic value of the three constituents of undifferentiated-type gastric adenocarcinoma remains unclear. The present study assessed the clinicopathological characteristics and prognosis of undifferentiated-type mucinous adenocarcinoma (uMAC) and signet ring cell carcinoma (SRC) compared with those of poorly differentiated adenocarcinoma (PDAC).

METHODS

In total, 1,376 patients with undifferentiated-type gastric adenocarcinoma were included, consisting of 1,002 patients diagnosed with PDAC, 54 with uMAC and 320 with SRC. Clinicopathological factors and survival rates were compared among the three histological types.

RESULTS

Significant differences in the distribution of pathological stages were observed among the groups. Patients with SRC had a significantly better survival rate than those with PDAC or uMAC, in both the all patients including non-curative resected patients and curative-resected groups. In addition, there was significant difference in survival between the PDAC and uMAC groups. Multivariate analysis suggested that age, gender, tumor depth, lymph node metastasis and curability significantly affected survival. Histological type was not an independent prognostic factor. There was no significant difference in the pattern of recurrence among the three groups.

CONCLUSIONS

The uMAC and SRC had worse and favorable prognosis compared with PDCA, respectively. However, there were no differences in survival by pathological stage, thus histological type was not an independent predictor of prognosis.

摘要

背景

未分化型胃腺癌的三种成分的预后价值尚不清楚。本研究评估了未分化型黏液性腺癌(uMAC)和印戒细胞癌(SRC)与低分化腺癌(PDAC)相比的临床病理特征和预后。

方法

共纳入 1376 例未分化型胃腺癌患者,包括 1002 例 PDAC 患者、54 例 uMAC 患者和 320 例 SRC 患者。比较三种组织学类型的临床病理因素和生存率。

结果

各组的病理分期分布存在显著差异。与 PDAC 或 uMAC 相比,SRC 患者的总生存率和根治性切除患者的生存率均显著提高。此外,PDAC 和 uMAC 组之间的生存率也存在显著差异。多因素分析表明,年龄、性别、肿瘤深度、淋巴结转移和可切除性显著影响生存。组织学类型不是独立的预后因素。三组的复发模式无显著差异。

结论

uMAC 和 SRC 的预后分别比 PDCA 差和较好。然而,病理分期无生存差异,因此组织学类型不是独立的预后预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a51/3538509/6a1d8822798a/1477-7819-10-254-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验